A FIM study to assess safety and exposure of inhaled single doses of AP301 - A specific ENaC channel activator for the treatment of acute lung injury

Richard Schwameis, Sandra Eder, Helmut Pietschmann, Bernhard Fischer, Hermann Mascher, Susan Tzotzos, Hendrik Fischer, Rudolf Lucas, Markus Zeitlinger, Robert Hermann

Research output: Contribution to journalArticle

15 Scopus citations

Fingerprint Dive into the research topics of 'A FIM study to assess safety and exposure of inhaled single doses of AP301 - A specific ENaC channel activator for the treatment of acute lung injury'. Together they form a unique fingerprint.

Medicine & Life Sciences